Pre-Clinical Study of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitor Cells for Parkinson’s Disease

By
Justin.choi
-
0
31
Scientists evaluated the safety and efficacy of dopaminergic progenitors (DAPs) derived from a clinical-grade human iPSC line. They confirmed the characteristics of DAPs by in vitro analyses.
[Nature Communications]

Sorry, but the selected Zotpress account can't be found.

Full Article